Sign in

Private company

Synthon

Logo: Synthon, CC BY-SA 4.0, via Wikimedia Commons3

Dutch pharmaceutical company

Synthon is a Dutch multinational that produces generic human drugs. The company was founded in 1991 by Jacques Lemmens and Marijn Oosterbaan, two organic chemists of the Radboud University Nijmegen. Synthon is active in the Netherlands, the Czech Republic, Spain, the United States, Argentina, Chile, Russia, Mexico and South Korea with about 1,500 employees.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1991Founded1

See how the biggest companies compare on our leaderboards

Synthon is a Dutch multinational that produces generic human drugs.2

The story

In 2007 the company started developing biopharmaceuticals.

In May 2012 Synthon announced that it bought the Biolex LEX System for manufacturing biopharmaceuticals in Lemna. The sale also included two preclinical biologics made with the LEX System, BLX-301, a humanized and glyco-optimized anti-CD20 antibody for non-Hodgkin's B-cell lymphoma and other B-cell malignancies and BLX-155, a direct-acting thrombolytic. The financial terms of the sale were not disclosed.

From Wikipedia’s article on Synthon (company), shared under CC BY-SA 4.0.4

Subsidiaries and ownership

Subsidiaries

  • Synthon

From Wikidata.1

Timeline

  1. 1991Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4